Company profile: Univercells Technologies
1.1 - Company Overview
Company description
- Provider of biomanufacturing services and platforms for cost-effective viral production from R&D to commercial scale, offering scale-X bioreactors (hydro, carbo) for adherent and suspension cells, the scale-X cell collect system, and the NevoLine Upstream platform integrating virus production, concentration, and clarification, plus services including equipment confirmation, capacity and facility design, and bioprocess excellence.
Products and services
- NevoLineâ„¢ Upstream platform: An integrated, commercial-scale, automated platform that combines virus production, concentration, and clarification in a compact footprint for upstream manufacturing
- Scale-Xâ„¢ bioreactor: A family of bioreactors with a unique structured fixed-bed design enabling scalable production of adherent and suspension cells and viral products from R&D to commercial sizes
- Scale-Xâ„¢ carbo system: An intermediate-scale bioreactor system architected to bridge process development to clinical production, enabling GMP production while connecting development-stage operations to clinical manufacturing
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Univercells Technologies
Telesis Bio
HQ: United States
Website
- Description: Provider of automated synthetic biology tools, including the BioXp benchtop platform to generate synthetic DNA and mRNA, and kits for mRNA synthesis, DNA cloning (up to 24 kb), error-corrected gene synthesis (up to 1.8 kb), library creation with site-saturation variants (NNN/NNK/IUPAC), and cell-free DNA amplification for transfection-scale output in under a day.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Telesis Bio company profile →
Icon Genetics
HQ: Germany
Website
- Description: Provider of agricultural biotechnology.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Icon Genetics company profile →
Magtivio
HQ: The Netherlands
Website
- Description: Provider of magnetic micro- and nano particles and complete kits for DNA extraction, circulating cfDNA analysis, NGS library preparation, and dye-terminator removal in Sanger sequencing, as well as magnetic separators.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Magtivio company profile →
Newport Labs
HQ: United States
Website
- Description: Provider of veterinary healthcare services and high-quality autogenous biologics for the livestock industry, applying 21st technology to a traditional autogenous approach to formulate products that pinpoint specific disease problems, supported by dedicated employees and innovative solutions.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Newport Labs company profile →
BioDot
HQ: United States
Website
- Description: Provider of automated low-volume, non-contact quantitative fluid dispensing systems and lamination, cutting, and assembly expertise. Platforms enable direct dispensing of lines and dots on membranes, papers, microwell plates, slides, and microfluidics, plus web handling and dip coating from roll stock and auto lamination, serving R&D through high-volume manufacturing in industrial, diagnostic, life science, and medical markets.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full BioDot company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Univercells Technologies
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Univercells Technologies
2.2 - Growth funds investing in similar companies to Univercells Technologies
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Univercells Technologies
4.2 - Public trading comparable groups for Univercells Technologies
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →